Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2020-03-30 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to the stock exchange regarding the closure of the trading window for insiders due to the upcoming declaration of audited financial results for the fiscal year ended March 31, 2020. It references regulatory guidelines on insider trading and trading restrictions but does not contain any financial data, results, or detailed report content. The document is an announcement related to trading restrictions ahead of financial results, not the financial report itself or its publication announcement. Given its nature and length (1048 characters), it fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2020-03-30 English
Updates
Director's Dealing Classification · 90% confidence The document contains a table listing dates of transactions, number of lots, and number of shares, indicating it reports on share transactions. There is no indication of a full report, financial data, or regulatory announcements. The content aligns with a report of personal share transactions by company directors or executives, which fits the Director's Dealing category.
2020-03-19 English
Updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. It details the acquisition of shares by a promoter, including dates, number of shares, percentage holdings before and after acquisition, and mode of acquisition (open market). The document is a regulatory filing related to shareholding changes and takeover regulations, specifically a substantial acquisition disclosure. It is not a full financial report, earnings release, or management report. It is not an announcement of a report publication but a direct regulatory disclosure. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ).
2020-03-18 English
Updates
Director's Dealing Classification · 95% confidence The document text is very short (196 characters) and contains tabular data about the purchase of equity shares by an entity named 'pyhaspurchased'. It lists dates, number of lots, and number of shares purchased. This matches the description of a report of personal share transactions by company directors or executives (insider trades). Therefore, the document is best classified as a Director's Dealing report (DIRS).
2020-03-18 English
Updates
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. It details the acquisition of shares by a promoter from the open market, including dates, number of shares, and percentage holdings before and after the acquisition. The document is a formal notification of a change in significant shareholding, specifically a substantial acquisition of shares by a promoter. It is not an annual report, earnings release, or any other financial report but a regulatory filing related to shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2020-03-16 English
Updates
Director's Dealing Classification · 95% confidence The document text is extremely short (301 characters) and appears to be a tabular record of share transactions by an individual named Vijay Kumar Batra, who is identified as a promoter. The content lists dates and numbers of shares purchased, which aligns with reporting of insider or director share dealings. There is no indication of financial statements, regulatory announcements, or other report types. Therefore, this document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2020-03-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.